INTERNATIONAL PATENT: LANOVA MEDICINES DEVELOPMENT CO., LTD. FILES APPLICATION FOR "CONJUGATES OF ANTI-SLC34A2 ANTIBODY AND USES THEREOF"

GENEVA, June 30 -- LANOVA MEDICINES DEVELOPMENT CO., LTD. (999 Cailun Road, Building 1, Floor 5,Pudong New Area, Shanghai 201203) filed a patent application (PCT/CN2024/140838) for "CONJUGATES OF ANTI-SLC34A2 ANTIBODY AND USES THEREOF" on Dec 20, 2024. With publication no. WO/2025/131025, the details related to the patent application was published on Jun 26, 2025.

Notably, the patent application was submitted under the International Patent Classification (IPC) system, which is managed by the World Intellectual Property Organization (WIPO).

Inventor(s): LI, Runsheng (999 Cailun Road, Building 1, Floor 5,Pudong New Area, Shanghai 201203), HUANG, Wentao (999 Cailun Road, Building 1, Floor 5,Pudong New Area, Shanghai 201203), ZANG, Ying Qin (...